Leslie Samuel

3.7k total citations
84 papers, 1.9k citations indexed

About

Leslie Samuel is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Leslie Samuel has authored 84 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Oncology, 21 papers in Surgery and 13 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Leslie Samuel's work include Colorectal Cancer Treatments and Studies (27 papers), Colorectal Cancer Surgical Treatments (20 papers) and Colorectal and Anal Carcinomas (16 papers). Leslie Samuel is often cited by papers focused on Colorectal Cancer Treatments and Studies (27 papers), Colorectal Cancer Surgical Treatments (20 papers) and Colorectal and Anal Carcinomas (16 papers). Leslie Samuel collaborates with scholars based in United Kingdom, United States and Spain. Leslie Samuel's co-authors include Simon Gollins, Peter Murchie, James T. Cassidy, Robert Grieve, Chris Twelves, Craig A. White, Neil J. Douglas, James Paul, Heather M. Engleman and Lynne Taylor and has published in prestigious journals such as Journal of Clinical Oncology, Physical review. B, Condensed matter and PLoS ONE.

In The Last Decade

Leslie Samuel

77 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Leslie Samuel United Kingdom	23	969	436	409	217	211	84	1.9k
Karleen Schulze Canada	25	782 0.8×	530 1.2×	705 1.7×	294 1.4×	88 0.4×	49	2.6k
Jinming Yu China	26	554 0.6×	451 1.0×	616 1.5×	92 0.4×	84 0.4×	138	2.1k
Lanwei Guo China	21	656 0.7×	354 0.8×	457 1.1×	77 0.4×	97 0.5×	108	1.6k
Nirmala Bhoo‐Pathy Malaysia	25	1.1k 1.2×	172 0.4×	301 0.7×	74 0.3×	232 1.1×	113	2.0k
Karen E. Bremner Canada	29	483 0.5×	186 0.4×	432 1.1×	66 0.3×	150 0.7×	95	2.2k
T. Urban France	28	1.6k 1.7×	218 0.5×	1.6k 3.8×	87 0.4×	98 0.5×	111	3.4k
Qiuling Shi China	34	1.8k 1.8×	628 1.4×	962 2.4×	74 0.3×	126 0.6×	248	4.1k
Corrado Ficorella Italy	27	1.2k 1.2×	273 0.6×	651 1.6×	40 0.2×	200 0.9×	140	2.6k
Peter S. Bunting Canada	25	500 0.5×	370 0.8×	695 1.7×	43 0.2×	109 0.5×	61	2.4k
John H. Fetting United States	28	1.6k 1.7×	194 0.4×	564 1.4×	59 0.3×	224 1.1×	73	3.2k

Countries citing papers authored by Leslie Samuel

Since Specialization

Citations

This map shows the geographic impact of Leslie Samuel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leslie Samuel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leslie Samuel more than expected).

Fields of papers citing papers by Leslie Samuel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leslie Samuel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leslie Samuel. The network helps show where Leslie Samuel may publish in the future.

Co-authorship network of co-authors of Leslie Samuel

This figure shows the co-authorship network connecting the top 25 collaborators of Leslie Samuel. A scholar is included among the top collaborators of Leslie Samuel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leslie Samuel. Leslie Samuel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Dey, Bidit Lal, et al.. (2025). Digital transformation or digital divide? Smes' use of AI during global crisis. Technological Forecasting and Social Change. 217. 124184–124184. 9 indexed citations

Wirapati, Pratyaksha, Yourae Hong, Leslie Samuel, et al.. (2024). Exploratory biomarker analysis for predicting treatment effects of aflibercept in the VELOUR trial.. Journal of Clinical Oncology. 42(16_suppl). 3592–3592.

Lafarge, Maxime W., Enric Domingo, Korsuk Sirinukunwattana, et al.. (2024). Image-based consensus molecular subtyping in rectal cancer biopsies and response to neoadjuvant chemoradiotherapy. npj Precision Oncology. 8(1). 89–89. 9 indexed citations

Samuel, Leslie, Rowan Miller, Paul J. Ross, et al.. (2023). P-164 Efficacy and safety of dostarlimab in UK-specific patients with mismatch repair deficient (dMMR)/microsatellite instability-high (MSI-H) or DNA polymerase epsilon, catalytic subunit (POLƐ)-mutated solid tumours in the GARNET study. Annals of Oncology. 34. S73–S74. 2 indexed citations

McDowell, Ronald, et al.. (2021). SO-25 Global rise in early-onset colorectal cancer: An association with antibiotic consumption?. Annals of Oncology. 32. S213–S213. 2 indexed citations

Bridgewater, John, Saifee Mullamitha, Michael Braun, et al.. (2020). 502P Nivolumab, alone or with ipilimumab, for mismatch repair deficient metastatic colorectal cancer: A United Kingdom multicentre analysis of patient outcomes. Annals of Oncology. 31. S453–S453.

Miedzybrodzka, Zosia, et al.. (2020). Young-onset colorectal cancer in the North East of Scotland: survival, clinico-pathological features and genetics. BMC Cancer. 20(1). 108–108. 12 indexed citations

Ramsay, George, et al.. (2018). Can Haematology Blood Tests at Time of Diagnosis Predict Response to Neoadjuvant Treatment in Locally Advanced Rectal Cancer?. Digestive Surgery. 36(6). 495–501. 9 indexed citations

Convertino, Matteo, Timothy R. Church, Geary W. Olsen, et al.. (2018). Stochastic Pharmacokinetic-Pharmacodynamic Modeling for Assessing the Systemic Health Risk of Perfluorooctanoate (PFOA). Toxicological Sciences. 163(1). 293–306. 39 indexed citations

10.

Richman, Susan D., Richard Adams, Ewan Brown, et al.. (2017). FOCUS4: MAMS Trial Design in Action. Early Closure of FOCUS4-D (Pan-HER 1, 2 and 3 Inhibitor Versus Placebo) in Advanced Colorectal Cancer (aCRC) Patients, with Tumours Wildtype (WT) for KRAS, NRAS, BRAF and PIK3CA. White Rose Research Online (University of Leeds, The University of Sheffield, University of York). 243. 1 indexed citations

11.

Lenz, Heinz‐Josef, Philip Philip, Mark Saunders, et al.. (2017). Randomized study of etirinotecan pegol versus irinotecan as second-line treatment for metastatic colorectal cancer. Cancer Chemotherapy and Pharmacology. 80(6). 1161–1169. 7 indexed citations

12.

Adams, Richard, Ewan Brown, Louise Brown, et al.. (2016). FOCUS4-D: Results from a randomised, placebo controlled trial (RCT) of AZD8931 (an inhibitor of signalling by HER1, 2, and 3) in patients (pts) with advanced or metastatic colorectal cancer (aCRC) in tumours that are wildtype (wt) for BRAF, PIK3CA, KRAS & NRAS. Annals of Oncology. 27. vi168–vi168. 3 indexed citations

13.

Murchie, Peter, Edwin Amalraj Raja, Amanda Lee, et al.. (2015). Effect of longer health service provider delays on stage at diagnosis and mortality in symptomatic breast cancer. The Breast. 24(3). 248–255. 8 indexed citations

14.

Murchie, Peter, Edwin Amalraj Raja, David Brewster, et al.. (2014). Time from first presentation in primary care to treatment of symptomatic colorectal cancer: effect on disease stage and survival. British Journal of Cancer. 111(3). 461–469. 58 indexed citations

15.

Tabernero, Josep, Rocio García‐Carbonero, James T. Cassidy, et al.. (2013). Sorafenib in Combination with Oxaliplatin, Leucovorin, and Fluorouracil (Modified FOLFOX6) as First-line Treatment of Metastatic Colorectal Cancer: The RESPECT Trial. Clinical Cancer Research. 19(9). 2541–2550. 69 indexed citations

16.

Gollins, Simon, Swe Swe Myint, S. Susnerwala, et al.. (2009). Preoperative downstaging chemoradiation with concurrent irinotecan and capecitabine in MRI-defined locally advanced rectal cancer: a phase I trial (NWCOG-2). British Journal of Cancer. 101(6). 924–934. 19 indexed citations

17.

Espie, Colin A., et al.. (2008). Cognitive and attentional changes following cognitive behaviour therapy (CBT) for persistent insomnia associated with cancer: a randomized controlled trial. SLEEP. 31. 1 indexed citations

18.

Graham, Janet S., et al.. (2008). A multi-centre dose-escalation and pharmacokinetic study of diflomotecan in patients with advanced malignancy. Cancer Chemotherapy and Pharmacology. 63(5). 945–952. 8 indexed citations

19.

Gourley, Charlie, James T. Cassidy, Leslie Samuel, et al.. (2004). A phase I study of the trinuclear platinum compound, BBR�3464, in combination with protracted venous infusional 5-fluorouracil in patients with advanced cancer. Cancer Chemotherapy and Pharmacology. 53(2). 95–101. 19 indexed citations

20.

Miller, N.E., J. Rajput-Williams, M. Nazeem Nanjee, Leslie Samuel, & J J Albers. (1988). Relationship of high density lipoprotein composition to plasma lecithin: cholesterol acyltransferase concentration in men. Atherosclerosis. 69(2-3). 123–129. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact